Deep learning has revolutionized various domains, and biomedical imaging is no exception. These advancements are due in no small part to the ability to learn and extract useful representations from complex datasets. Traditional approaches involve pretraining models on extensive natural image
As climate change accelerates, the world is witnessing profound environmental transformations that significantly impact public health. These shifts don’t just cause rising ocean levels or sporadic extreme weather but also alter ecosystems in ways that trigger significant public health consequences.
Ear reconstruction is one of the most challenging tasks in reconstructive surgery, demanding both structural integrity and aesthetic appeal. Recreating the outer ear, or auricle, involves achieving both structural integrity and aesthetic appeal, a complex endeavor even for an experienced surgeon.
Xeris Biopharma Holdings Inc. (NASDAQ: XERS) recently experienced a slight dip in its stock value, closing at $2.48, down -1.59% from the previous day. However, with positive analyst ratings, significant insider buying, and strong institutional support, there are several optimistic indicators for
Legend Biotech, widely recognized for its collaboration with Johnson & Johnson (J&J) on the BCMA CAR-T therapy Carvykti, has found itself at the center of buyout speculation, which has reverberated across biotech markets. Reports of an acquisition bid prompted the company to engage Centerview
The introduction of the BIOSECURE Act marks a significant moment in U.S. legislative history, specifically targeting the intersection of national security and biotechnology. This proposed legislation aims to halt federal contracts with Chinese biotech firms, citing potential national security
In recent years, the intersection of advanced computing and biological research has elevated the prospects of drug discovery to unprecedented heights. The seamless integration of AI, machine learning, and supercomputing promises a paradigmatic shift from traditional empiricism to computational
In a significant move within the pharmaceutical manufacturing industry, Veranova has announced a substantial $30 million investment to enhance its Devens, Massachusetts facility. This strategic expansion is designed to bolster Veranova’s capabilities in developing and manufacturing antibody-drug
Artificial Intelligence (AI) is poised to transform drug discovery, ushering in an era of unprecedented innovation in the pharmaceutical industry. The promise of developing numerous high-quality drug candidates quickly and cost-effectively is becoming a reality. However, this revolution also brings
In a bold move that underscores the dynamism of the pharmaceutical industry, Ono Pharmaceutical Co., Ltd. has executed a major acquisition of Deciphera Pharmaceuticals Inc. The deal, valued at a hefty $2.4 billion, positions Ono strategically as a more influential player on the global stage,
